Farsinejad S, Centeno D, Savas-Carstens J, Polotaye T, Pavlovič T, Babvey P, Muranen T, Miedziarek C, Jasiński P, Dziabaszewska E, Zaborowski MP, Lum PY, Martin LA, Iwanicki MP

Suppression of Ovarian Cancer Cell Proliferation Is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin
2025 Cancers, 17(9), 1472; DOI: 10.3390/cancers17091472

Farsinejad S, Centeno D, Carstens JS, Polotaye T, Pavlovic T, Babvey P, Muranen T, Lum PY, Martin LA, Iwanicki MP

Suppression of Ovarian Cancer Cell Proliferation is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin
2025 bioRxiv 2025.02.10.637535; DOI: https://doi.org/10.1101/2025.02.10.637535

Zhou X, Berenger E, Shi Y, Shirokova V, Kochetkova E, Becirovic T, Zhang B, Kaminskyy VO, Esmaeilian Y, Hosaka K, Lindskog C, Hydbring P, Ekman S, Cao Y, Genander M, Iwanicki M, Norberg E, Vakifahmetoglu-Norberg H

Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors
2025 EMBO Mol Med. 2025 Mar 7. DOI: 10.1038/s44321-025-00210-w. PMID: 40055574

Puleo N, Ram H, Dziubinski ML, Carvette D, Teitel J, Sekhar SC, Bedi K, Robida A, Nakashima MM, Farsinejad S, Iwanicki M, Senkowski W, Ray A, Bollerman TJ, Dunbar J, Richardson P, Taddei A, Hudson C, DiFeo A

Identification of a TNIK-CDK9 axis as a targetable strategy for platinum-resistant ovarian cancer
2025 Mol Cancer Ther. 2025 Jan 28. DOI: 10.1158/1535-7163.MCT-24-0785. PMID: 39873147

Teagan Polotaye, Daniel Centeno and Marcin Iwanicki

Mutant p53R175H-Associated Protection of Ovarian Cancer Precursor Cells from Cisplatin Requires Expression of SLC6A6 Taurine Transporter
2024 Journal of Student Research, volume 13 issue 3 (2024); ISSN: 2167-1907

Michael Greenberg, Aleksandra Gladych-Macioszek, Agnieszka Klupczynska-Gabryszak, Szymon Plewa, Jan Matysiak, Mikolaj Zaborowski, Marcin Iwanicki and Daniel Centeno

Taurine But Not Proline Protects Cells from Cisplatin, Activates p21, and Fibronectin Expression
2024 Journal of Student Research, volume 13 issue 3 (2024); ISSN: 2167-1907

Daniel Centeno, Sadaf Farsinejad, Elena Kochetkova, Tatiana Volpari, Aleksandra Gladych-Macioszek, Agnieszka Klupczynska-Gabryszak, Teagan Polotaye, Michael Greenberg, Douglas Kung, Emily Hyde, Sarah Alshehri, Tonja Pavlovic, William Sullivan, Szymon Plewa, Helin Vakifahmetoglu-Norberg, Frederick J Monsma Jr, Patricia A J Muller, Jan Matysiak, Mikołaj Piotr Zaborowski, Analisa DiFeo, Erik Norberg, Laura A Martin, Marcin Iwanicki

Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection
2024 PMCID: PMC11206249 DOI: 10.3390/nu16121816

Doberstein K, Spivak R, Reavis HD, Hooda J, Feng Y, Kroeger PT Jr, Stuckelberger S, Mills GB, Devins KM, Schwartz LE, Iwanicki MP, Fogel M, Altevogt P, Drapkin R

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
2022 Commun Biol. 2022 Dec 12;5(1):1362. DOI: 10.1038/s42003-022-04314-8. PMID: 36509990

Sarah Alshehri, Tonja Pavlovič, Sadaf Farsinejad, Panteha Behboodi, Li Quan, Daniel Centeno, Douglas Kung, Marta Rezler, Woo Lee, Piotr Jasiński, Elżbieta Dziabaszewska, Ewa Nowak-Markwitz, Dilhan Kalyon, Mikołaj P. Zaborowski, Marcin Iwanicki

Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer
2022 Advanced Biology, September 2022; DOI: 10.1002/adbi.202200197

Tangri A, Lighty K, Loganathan J, Mesmar F, Podicheti R, Zhang C, Iwanicki M, Drapkin R, Nakshatri H, Mitra S

Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma
2021 Mol Cancer Res. 2021 Mar 22. DOI: 10.1158/1541-7786.MCR-20-0883. PMID: 33753553

Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P, Iwanicki M, Walker SR, Kanodia A, Melms JC, Mei S, Lin JR, Porter CBM, Slyper M, Waldman J, Jerby-Arnon L, Ashenberg O, Brinker TJ, Mills C, Rogava M, Vigneau S, Sorger PK, Garraway LA, Konstantinopoulos PA, Liu JF, Matulonis U, Johnson BE, Rozenblatt-Rosen O, Rotem A, Regev A

A Single-Cell Landscape of High-Grade Serous Ovarian Cancer
2020 Nat Med. 2020 Jun 22. DOI: 10.1038/s41591-020-0926-0. PMID: 32572264

Kozlova N, Grossman JE, Iwanicki MP, Muranen T

The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers
2020 Trends Pharmacol Sci. 2020 Jan 31. DOI: 10.1016/j.tips.2020.01.001

Farsinejad S, Cattabiani T, Muranen T, Iwanicki M

Ovarian Cancer Dissemination-A Cell Biologist’s Perspective
2019 Cancers (Basel). 2019 Dec 6;11(12). DOI: 10.3390/cancers11121957. PMID: 31817625

Zaborowski MP, Lee K, Na YJ, Sammarco A, Zhang X, Iwanicki M, Cheah PS, Lin HY, Zinter M, Chou CY, Fulci G, Tannous BA, Lai CP, Birrer MJ, Weissleder R, Lee H, Breakefield XO

Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles
2019 Cell Rep. 2019 Apr 2;27(1):255-268.e6. DOI: 10.1016/j.celrep.2019.03.003. PMID: 30943406

Medrano M, Communal L, Brown KR, Iwanicki M, Normand J, Paterson J, Sircoulomb F, Krzyzanowski P, Novak M, Doodnauth SA, Saiz FS, Cullis J, Al-Awar R, Neel BG, McPherson J, Drapkin R, Ailles L, Mes-Massons AM, Rottapel R

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer
2017 Cell Rep. 2017 Mar 7;18(10):2343-2358. DOI: 10.1016/j.celrep.2017.02.028. PMID: 28273451

Muranen T, Iwanicki MP, Curry NL, Hwang J, DuBois CD, Coloff JL, Hitchcock DS, Clish CB, Brugge JS, Kalaany NY

Starved epithelial cells uptake extracellular matrix for survival
2017 Nat Commun. 2017 Jan 10;8:13989. DOI: 10.1038/ncomms13989. PMID: 28071763

Sheets JN, Iwanicki M, Liu JF, Howitt BE, Hirsch MS, Gubbels JA, Drapkin R, Egland KA

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance
2016 Oncogenesis. 2016 Oct 24;5(10):e264. DOI: 10.1038/oncsis.2016.64. PMID: 27775699

Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R, Brugge JS

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
2016 JCI Insight. 2016 Jul 7;1(10). DOI: 10.1172/jci.insight.86829. PMID: 27482544

Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
2015 Nat Rev Cancer. 2015 Nov;15(11):668-79. DOI: 10.1038/nrc4019. PMID: 26493647

Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS

Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
2014 J Clin Invest. 2014 Jun;124(6):2611-25. DOI: 10.1172/JCI69815. PMID: 24762435

Muranen T, Selfors LM, Worster DT, Iwanicki MP, Song L, Morales FC, Gao S, Mills GB, Brugge JS

Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells
2012 Cancer Cell. 2012 Feb 14;21(2):227-39. DOI: 10.1016/j.ccr.2011.12.024. PMID: 22340595

Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, Danuser G, Ince TA, Brugge JS

Ovarian cancer spheroids use myosin-generated force to clear the mesothelium
2011 Cancer Discov. 2011 Jul;1(2):144-57. DOI: 10.1158/2159-8274.CD-11-0010. PMID: 22303516

Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL, Gosselin P, Cromer A, Brugge JS, Sansom OJ, Norman JC, Vousden KH

Mutant p53 drives invasion by promoting integrin recycling
2009 Cell. 2009 Dec 24;139(7):1327-41. DOI: 10.1016/j.cell.2009.11.026. PMID: 20064378